IBOV 177,098 ▼ 1.80% COLCAP 2,118 ▼ 0.22% MERVAL 2,738,355 ▼ 1.96% IPC MEX 70,187 ▲ 0.22% BVL PERÚ 19,767 ▲ 0.37% STOXX 50 5,861 ▲ 0.91% DAX 24,137 ▲ 0.76% CAC 8,008 ▲ 0.35% FTSE 10,325 ▲ 0.58% IBEX 17,655 ▲ 0.46% FTSE MIB 49,481 ▲ 1.00% AEX 1,010 ▲ 1.07% OMXS30 3,048 ▲ 0.05% WIG 132,379 ▲ 1.71% PSI 9,072 ▲ 0.24% SMI 13,213 ▲ 0.71% BEL 20 5,509 ▲ 0.71% S&P 500 7,444 ▲ 0.58% DOW 49,693 ▼ 0.14% NASDAQ 26,402 ▲ 1.20% RUSSELL 2,844 ▲ 0.04% TSX 34,041 ▼ 0.73% NIKKEI 63,558 ▲ 0.45% HANG SENG 26,604 ▲ 0.82% SHANGHAI 4,222 ▼ 0.50% SHENZHEN 15,947 ▼ 0.89% KOSPI 7,931 ▲ 1.11% KOSDAQ 1,168 ▼ 0.79% TWSE 41,703 ▲ 0.79% SENSEX 74,609 ▲ 0.07% NIFTY 23,413 ▲ 0.14% PSEi 5,968 ▲ 0.36% JCI 6,723 ▼ 1.98% KLCI 1,746 ▼ 0.02% STI 4,989 ▼ 0.31% SET 1,517 ▲ 2.27% ASX 200 8,610 ▼ 0.24% NZX 50 13,015 ▼ 0.37% JSE TOP 40 109,782 ▲ 0.66% EGX 30 53,416 ▼ 1.19% TASI 11,020 ▼ 0.17% USD/BRL 5.01 ▲ 2.07% USD/COP 3,783 ▼ 0.10% USD/ARS 1,392 ▲ 0.47% USD/MXN 17.16 ▼ 0.37% USD/PEN 3.42 ▲ 1.71% EUR/BRL 5.87 ▲ 1.89% EUR/USD 1.17 ▼ 0.15% GBP/USD 1.35 ▼ 0.10% USD/JPY 157.93 ▲ 0.16% USD/CNY 6.79 ▼ 0.06% USD/INR 95.62 ▼ 0.01% USD/KRW 1,492 ▼ 0.06% USD/ZAR 16.42 ▼ 0.58% USD/NGN 1,368 ▼ 0.18% USD/EGP 52.87 — 0.00% USD/TRY 45.42 ▲ 0.05% USD/RUB 73.59 ▼ 0.32% USD/CHF 0.78 ▲ 0.17% USD/CAD 1.37 ▲ 0.07% USD/HKD 7.83 ▲ 0.03% USD/SGD 1.27 ▲ 0.06% BRENT 105.62 ▼ 1.99% WTI 101.09 ▼ 1.07% GOLD 4,697 ▲ 0.41% SILVER 87.90 ▲ 3.25% COPPER 6.60 ▲ 1.77% NATGAS 2.87 ▲ 1.06% IRON ORE 161.91 ▲ 45.32% BTC 79,583 ▼ 1.11% ETH 2,263 ▼ 0.50% SELIC 14.50% IBOV 177,098 ▼ 1.80% COLCAP 2,118 ▼ 0.22% MERVAL 2,738,355 ▼ 1.96% IPC MEX 70,187 ▲ 0.22% BVL PERÚ 19,767 ▲ 0.37% STOXX 50 5,861 ▲ 0.91% DAX 24,137 ▲ 0.76% CAC 8,008 ▲ 0.35% FTSE 10,325 ▲ 0.58% IBEX 17,655 ▲ 0.46% FTSE MIB 49,481 ▲ 1.00% AEX 1,010 ▲ 1.07% OMXS30 3,048 ▲ 0.05% WIG 132,379 ▲ 1.71% PSI 9,072 ▲ 0.24% SMI 13,213 ▲ 0.71% BEL 20 5,509 ▲ 0.71% S&P 500 7,444 ▲ 0.58% DOW 49,693 ▼ 0.14% NASDAQ 26,402 ▲ 1.20% RUSSELL 2,844 ▲ 0.04% TSX 34,041 ▼ 0.73% NIKKEI 63,558 ▲ 0.45% HANG SENG 26,604 ▲ 0.82% SHANGHAI 4,222 ▼ 0.50% SHENZHEN 15,947 ▼ 0.89% KOSPI 7,931 ▲ 1.11% KOSDAQ 1,168 ▼ 0.79% TWSE 41,703 ▲ 0.79% SENSEX 74,609 ▲ 0.07% NIFTY 23,413 ▲ 0.14% PSEi 5,968 ▲ 0.36% JCI 6,723 ▼ 1.98% KLCI 1,746 ▼ 0.02% STI 4,989 ▼ 0.31% SET 1,517 ▲ 2.27% ASX 200 8,610 ▼ 0.24% NZX 50 13,015 ▼ 0.37% JSE TOP 40 109,782 ▲ 0.66% EGX 30 53,416 ▼ 1.19% TASI 11,020 ▼ 0.17% USD/BRL 5.01 ▲ 2.07% USD/COP 3,783 ▼ 0.10% USD/ARS 1,392 ▲ 0.47% USD/MXN 17.16 ▼ 0.37% USD/PEN 3.42 ▲ 1.71% EUR/BRL 5.87 ▲ 1.89% EUR/USD 1.17 ▼ 0.15% GBP/USD 1.35 ▼ 0.10% USD/JPY 157.93 ▲ 0.16% USD/CNY 6.79 ▼ 0.06% USD/INR 95.62 ▼ 0.01% USD/KRW 1,492 ▼ 0.06% USD/ZAR 16.42 ▼ 0.58% USD/NGN 1,368 ▼ 0.18% USD/EGP 52.87 — 0.00% USD/TRY 45.42 ▲ 0.05% USD/RUB 73.59 ▼ 0.32% USD/CHF 0.78 ▲ 0.17% USD/CAD 1.37 ▲ 0.07% USD/HKD 7.83 ▲ 0.03% USD/SGD 1.27 ▲ 0.06% BRENT 105.62 ▼ 1.99% WTI 101.09 ▼ 1.07% GOLD 4,697 ▲ 0.41% SILVER 87.90 ▲ 3.25% COPPER 6.60 ▲ 1.77% NATGAS 2.87 ▲ 1.06% IRON ORE 161.91 ▲ 45.32% BTC 79,583 ▼ 1.11% ETH 2,263 ▼ 0.50% SELIC 14.50%
since 2009
Thursday, May 14, 2026

Colombian softgel maker Procaps in talks to go public on Nasdaq – sources

By · March 15, 2021 · 2 min read

RIO DE JANEIRO, BRAZIL – Barranquilla-based softgel maker Procaps S.A.S. is in talks to go public on Nasdaq through a merger with U.S. blank-check company Union Acquisition Corp II in a deal which would value it at more than US$1 billion, people familiar with the matter said on Monday, March 15th.

Union Acquisition Corp II is in the process of engaging with potential investors to raise a US$100 million private investment in public equity, or PIPE, which would provide additional funding to Procaps, the sources said.

These funds would be used in addition to the US$200 million Union Acquisition Corp II raised in October 2019 through an initial public offering (IPO) on Nasdaq.

A deal with Procaps could be announced as soon as this month, the sources said. The sources, who cautioned that a deal could still fail to materialize, requested anonymity to discuss the deal.

A spokesman for Union Acquisition Corp II declined to comment. Procaps did not immediately respond to requests for comment.

Procaps was founded in 1977 and is based in Barranquilla, Colombia. It researches how to deliver medicines to patients through different forms, like softgels, chewable medicines, or by coating pills to make them taste more pleasant to patients.

Through the merger Union Acquisition Corp II, there is scope to grow Procaps organically and through acquisitions, one of the sources said.

The global softgel capsule market is seen growing to US$3.3 billion by 2023 from US$2.4 billion in 2017, according to a study by 360 Market Updates.

Procaps’ investors include the World Bank’s International Finance Corporation (IFC) and Alejandro Weinstein, who was previously CEO of generic drugmaker CFR Pharmaceuticals SA which was acquired by Abbott Laboratories in 2014.

Union Acquisition Corp II is the second so-called special purpose acquisition company (SPAC) led by Kyle Bransfield. SPACs are shell companies which raise funds in an initial public offering with the goal of merging with an unidentified private company.

For the company being acquired, the merger is an alternative way to go public over a traditional IPO. SPACs emerged last year as one of the most popular investment vehicles on Wall Street.

 

Read More from The Rio Times

Latin American financial intelligence, daily

Breaking news, market reports, and intelligence briefs — for investors, analysts, and expats.

Rotate for Best Experience

This report is optimized for landscape viewing. Rotate your phone for the full experience.